Who will compensate for the injuries sustained during participation in a new drug clinical trial?
In the event of injuries during clinical trials of new drugs, the sponsor and the trial institutions shall bear legal responsibility in accordance with Article 1008 of the Civil Code. The GCP requires the sponsor to provide compensation or insurance; consent forms, study protocols, and evidence of damages must be preserved.
Learn more >